Cite
HARVARD Citation
Eggermont, A. et al. (2021). The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model. European journal of cancer. pp. 518-519. [Online].